Ticker brief
ARWR
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
5
authors 14d
4
crowd 14d
+0.2σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-17 → 2026-08-28 · now +0.00 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Markadiusz45 | C | +1.18 | 2 | +0.20 |
| @OzmosiHealth | C | · | 1 | +0.35 |
| @StockPatternPro | C | -0.32 | 1 | +0.80 |
| @BiopharmIQ | B | · | 1 | +0.00 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-28 | @BiopharmIQ | +0.00 | Explains CELU's 139% move and lists upcoming biotech regulatory catalysts | · | tweet ↗ |
| 2026-08-22 | @StockPatternPro | +0.80 | Recaps ARWR rising from 24 when shared to above 87. | · | tweet ↗ |
| 2026-08-19 | @Markadiusz45 | +0.15 | Lists neglected RNA-related charts generated by ChatGPT. | · | tweet ↗ |
| 2026-08-19 | @Markadiusz45 | +0.25 | Suggests an emerging RNA-stock season and supplies a multi-name thematic basket. | · | tweet ↗ |
| 2026-08-17 | @OzmosiHealth | +0.35 | Reports German patient access to REDEMPLO as a new triglyceride treatment. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.